ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 182 filers reported holding ACORDA THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is 4.57 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $4,000 | -50.0% | 217 | -40.7% | 0.00% | -66.7% |
| Q3 2016 | $8,000 | -20.0% | 366 | -3.2% | 0.01% | -14.3% |
| Q2 2016 | $10,000 | -9.1% | 378 | 0.0% | 0.01% | -12.5% |
| Q1 2016 | $11,000 | -38.9% | 378 | -8.3% | 0.01% | -38.5% |
| Q4 2015 | $18,000 | +50.0% | 412 | 0.0% | 0.01% | +44.4% |
| Q3 2015 | $12,000 | -14.3% | 412 | -1.4% | 0.01% | -18.2% |
| Q2 2015 | $14,000 | 0.0% | 418 | 0.0% | 0.01% | 0.0% |
| Q1 2015 | $14,000 | -17.6% | 418 | +0.7% | 0.01% | -35.3% |
| Q4 2014 | $17,000 | – | 415 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SCOPIA CAPITAL MANAGEMENT LP | 7,106,955 | $139,652,000 | 2.69% |
| Malaga Cove Capital, LLC | 52,987 | $1,035,000 | 0.56% |
| PFM Health Sciences, LP | 1,699,100 | $33,387,000 | 0.49% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 75,000 | $1,474,000 | 0.43% |
| Spark Investment Management LLC | 320,400 | $6,295,000 | 0.36% |
| PFM Health Sciences, LP | 1,247,434 | $24,512,000 | 0.36% |
| Partner Investment Management, L.P. | 20,900 | $411,000 | 0.32% |
| Kazazian Asset Management, LLC | 14,454 | $284,000 | 0.27% |
| DLD Asset Management, LP | 271,500 | $5,327,000 | 0.26% |
| Partner Investment Management, L.P. | 15,516 | $305,000 | 0.23% |